Calculate luteal phase length from cycle data, assess luteal phase deficiency risk, estimate implantation window, and interpret progesterone levels.
The luteal phase — the interval between ovulation and the onset of menstruation — is critical for establishing and maintaining early pregnancy. A normal luteal phase of 12-14 days provides adequate time for the endometrium to develop under progesterone's influence, creating a receptive environment for embryo implantation. When the luteal phase falls below 10 days, it may indicate inadequate progesterone support and is termed luteal phase deficiency (LPD), a recognized factor in both infertility and early pregnancy loss.
This calculator estimates your luteal phase length using three input methods: average cycle length (assumes ovulation 14 days before period), known ovulation day, or BBT temperature shift date. It calculates the implantation window (typically 6-12 days post-ovulation), expected next period, and earliest reliable pregnancy test date. An optional mid-luteal progesterone level assessment helps evaluate whether the corpus luteum is producing adequate hormonal support.
Understanding your luteal phase is particularly valuable for women trying to conceive, those with recurrent early pregnancy loss, and anyone tracking cycle health. While individual cycles vary, consistently short luteal phases (< 10 days across 3+ cycles) warrant evaluation by a reproductive endocrinologist.
Understanding your luteal phase provides insight into fertility potential, hormonal balance, and cycle regularity. This calculator helps identify potential luteal phase deficiency, calculates the implantation window for conception timing, and provides context for interpreting progesterone levels — all important for women trying to conceive or evaluating cycle health. Keep these notes focused on your operational context. Tie the context to the calculator’s intended domain.
Luteal Phase Length = Cycle Length − Ovulation Day. For cycle-based estimation: Ovulation Day ≈ Cycle Length − 14 (luteal phase is relatively constant at ~14 days). Implantation Window = Ovulation + 6 to Ovulation + 12 days.
Result: Luteal phase = 14 days (normal), next period in 14 days from ovulation, progesterone normal mid-luteal
With a 30-day cycle and ovulation on day 16, the luteal phase is 30 − 16 = 14 days, which is within the normal range. Mid-luteal progesterone of 15 ng/mL confirms adequate corpus luteum function.
Luteal phase deficiency (LPD) is defined as insufficient progesterone production or endometrial response during the luteal phase. However, diagnosis remains controversial in reproductive endocrinology. The 2015 ASRM Practice Committee opinion states that there's no reliable diagnostic test for LPD in clinical practice — endometrial biopsy dating (the traditional gold standard) has poor inter-observer reliability and doesn't consistently correlate with fertility outcomes. Most clinicians rely on a combination of short luteal phase length (< 10 days), low mid-luteal progesterone (< 10 ng/mL), and clinical presentation.
When LPD is contributing to infertility or recurrent loss, treatment options include progesterone supplementation (vaginal progesterone 200mg daily or IM progesterone in oil), clomiphene citrate to improve follicular development (and subsequently corpus luteum quality), letrozole, and gonadotropin therapy. Human chorionic gonadotropin (hCG) injections can also rescue a failing corpus luteum. Treatment selection depends on whether the issue is primarily a corpus luteum problem or reflects broader ovulatory dysfunction.
Progesterone transforms the proliferative endometrium into a secretory endometrium capable of supporting embryo implantation. It opens the "window of implantation" during cycle days 20-24 (approximately 6-10 DPO) by inducing pinopodes on the endometrial surface, modulating immune function (promoting tolerance of the semi-allogeneic embryo), and suppressing uterine contractions. Inadequate progesterone results in endometrial asynchrony — the tissue isn't prepared when the embryo arrives for implantation.
A normal luteal phase ranges from 10 to 16 days, with 12-14 days being most common. Unlike the follicular phase (first half of cycle), which can vary widely, the luteal phase is relatively consistent from cycle to cycle for an individual woman. This consistency is why luteal phase length is used to estimate ovulation timing.
Short luteal phases (< 10 days) can result from inadequate follicular development (leading to a weak corpus luteum), hyperprolactinemia, thyroid disorders, polycystic ovary syndrome, excessive exercise, undernutrition, or physiologic factors like the perimenopause transition. Stress and recent discontinuation of hormonal contraception can also temporarily shorten the luteal phase.
Yes. A luteal phase shorter than 10 days may not provide enough time for an embryo to implant and establish pregnancy before progesterone withdrawal triggers menstruation. However, LPD as a sole cause of infertility is debated — it often accompanies other ovulatory dysfunction. Progesterone supplementation is a common treatment.
The ideal timing is 5-9 days after confirmed ovulation (approximately cycle day 21 in a 28-day cycle). A single level > 3 ng/mL confirms ovulation, and levels > 10 ng/mL suggest adequate luteal support. However, progesterone is secreted in pulses, so a single low reading doesn't definitively diagnose LPD — serial measurements or endometrial biopsy may be needed.
After ovulation, the corpus luteum produces progesterone, which raises basal body temperature by 0.3-0.5°C (0.5-1°F). A sustained temperature rise of ≥ 3 consecutive mornings confirms ovulation occurred. However, BBT only confirms ovulation retrospectively — it cannot predict it in advance. OPKs (ovulation predictor kits) detect the LH surge 24-36 hours before ovulation.
Luteal phase length typically remains stable until the late reproductive years (40s). As perimenopause approaches, follicular dynamics change — follicular phases may shorten first, then become erratic. The luteal phase may also shorten slightly as corpus luteum function declines, but this varies widely between individuals.